Related references
Note: Only part of the references are listed.Relative nephroprotection during Escherichia coli O157:H7 infections:: Association with intravenous volume expansion
JA Ake et al.
PEDIATRICS (2005)
Verotoxin (Shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: Possible implications for the hemolytic uremic syndrome
M Bitzan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children - A randomized controlled trial
H Trachtman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis
CS Wong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis -: A meta-analysis
N Safdar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
The central Scotland Escherichia coli O157:H7 outbreak:: Risk factors for the hemolytic uremic syndrome and death among hospitalized patients
S Dundas et al.
CLINICAL INFECTIOUS DISEASES (2001)
Escherichia coli O157:H7
PI Tarr et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2001)
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
CS Wong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response
PT Kimmitt et al.
EMERGING INFECTIOUS DISEASES (2000)
Share Paper
